Abstract Details
|
Lauren E. Dunn, MD
(Ochsner Health System)
PRESENTER |
Dr. Dunn has nothing to disclose. |
| Deanna Saylor, MD, MHS (Johns Hopkins Hospital) | The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities. |
| No disclosure on file | |
| David Yousem, MD | No disclosure on file |
| No disclosure on file | |
| Victor C. Urrutia, MD (Johns Hopkins University School of Medicine) | Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Director of CME course with PeerView. |